Vai al contenuto

Interazioni tra farmaci

Anakinra + Denosumab

Gravità: Moderata

Anakinra and Denosumab: moderate interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Anakinra blocks IL-1 and carries a risk of serious infection, and denosumab labeling advises caution with concomitant immunosuppressants. Combined use may further increase infection risk.

Cosa significa questa interazione in parole semplici

Anakinra and Denosumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Anakinra belongs to Musculoskeletal; Denosumab belongs to Oncology.

Livello di evidenza: Low

Perché avviene

Additive infection risk from IL-1 receptor blockade and RANKL inhibition; no pharmacokinetic mechanism.

Cosa fare

Monitor for signs of infection and treat early. Interrupt therapy if a serious infection develops.

Cosa chiedere al farmacista

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Anakinra e Denosumab, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Anakinra with Denosumab?

MediHelp rates the interaction as moderate. Anakinra and Denosumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Anakinra blocks IL-1 and carries a risk of serious infection, and denosumab labeling advises caution with concomitant immunosuppressants. Combined use may further increase infection risk.

How serious is the interaction between Anakinra and Denosumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of infection and treat early. Interrupt therapy if a serious infection develops.

What other medicines interact with Anakinra?

MediHelp also lists interactions of Anakinra with, for example, Bcg vaccine live, Measles mumps and rubella vaccine, Measles mumps and rubella vaccine live. The full list is on the Anakinra page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi